Clinical Trial Update: Dynamic F-DOPA PET for Differential Diagnosis Between Recurrence and Radionecrosis of Brain Metastasis [NA]

View source ↗

Summary

Completed clinical trial evaluating dynamic F-DOPA PET to differentiate recurrence from radionecrosis in patients with brain metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Radiation Necrosis

Drugs mentioned

• 18F-Fluorodopa (fluorodopa (18F))

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Brain Metastases, Radiation Necrosis | NA | Status: COMPLETED